Search

Search Constraints

You searched for: Author/Creator Flechtner, Jessica B.

Search Results

1. 1333Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year. (December 2014)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

3. Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples. Issue 33 (19th July 2016)

4. Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial. (30th January 2017)